Occurrence of OXA-48 Carbapenemase and Other β-Lactamase Genes in ESBL-Producing Multidrug Resistant Escherichia coli from Dogs and Cats in the United … X Liu, K Thungrat, DM Boothe Frontiers in microbiology 7, 1057, 2016 | 120 | 2016 |
Antimicrobial susceptibility patterns of clinical Escherichia coli isolates from dogs and cats in the United States: January 2008 through January 2013 K Thungrat, SB Price, DM Carpenter, DM Boothe Veterinary Microbiology 179 (3-4), 287-295, 2015 | 70 | 2015 |
Uterine bacterial isolates from mares and their resistance to antimicrobials: 8,296 cases (2003–2008) HA Davis, MB Stanton, K Thungrat, DM Boothe Journal of the American Veterinary Medical Association 242 (7), 977-983, 2013 | 63 | 2013 |
Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals X Liu, DM Boothe, K Thungrat, S Aly Veterinary microbiology 161 (1-2), 159-168, 2012 | 59 | 2012 |
Multilocus Sequence Typing and Virulence Profiles in Uropathogenic Escherichia coli Isolated from Cats in the United States X Liu, K Thungrat, DM Boothe PloS one 10 (11), e0143335, 2015 | 55 | 2015 |
In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States X Liu, DM Boothe, Y Jin, K Thungrat World Journal of Microbiology and Biotechnology 29, 347-354, 2013 | 23 | 2013 |
Quality assessment of fluconazole capsules and oral suspensions compounded by pharmacies located in the United States CM Laporte, C Cruz-Espindola, K Thungrat, AE Schick, TP Lewis, ... American Journal of Veterinary Research 78 (4), 421-432, 2017 | 12 | 2017 |
In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates X Liu, C Lazzaroni, SA Aly, K Thungrat, DM Boothe Veterinary Microbiology 174 (3-4), 514-522, 2014 | 8 | 2014 |
Treatment of canine diabetes mellitus using Momordica charantia capsule and a restricted-fat high-fiber diet K Thungrat, P Pusoonthornthum, K Fish, S Yibchok-anun J Med Plant Res 4, 2243-2251, 2010 | 3 | 2010 |
Cannabinoids in cancer: Cross-talk between cannabinoids and miRNAs JM Salamat, EL Ledbetter, KL Abbott, K Thungrat, PC Flannery, ... Cannabis/marijuana for healthcare, 53-75, 2022 | 2 | 2022 |
Objective: The aim of this study was to explore the occurrence and molecular characteri zation of extended-spectrum β-lactamases (ESBL), plasmid-mediated AmpC β-lactamase … A Novais, X Liu, R Antimicrobials, X Liu, K Thungrat, DM Boothe Genet. Acquir. Antimicrob. Resist. Anim. Zoonotic Pathog 203 (2018), 130-139, 2018 | 1 | 2018 |
Evaluation of a fluorescence resonance energy transfer quantitative polymerase chain reaction assay for identification of gyrA mutations conferring enrofloxacin resistance in … MG Behringer, DM Boothe, K Thungrat American journal of veterinary research 79 (7), 755-761, 2018 | | 2018 |
Mupirocin resistance in methicillin-resistant Staphylococcus pseudintermedius from canine and feline clinical samples. P Chanchaithong, N Suanpairintr, K Thungrat, S Surachetpong, ... | | 2017 |
Occurrence of OXA-48 carbapenemase and other β-lactamase genes in ESBL-producing multidrug resistant Escherichia coli from dogs and cats in the United … LXQ Liu XiaoQiang, K Thungrat, DM Boothe | | 2016 |
Prevention AMR: a dose selection for antimicrobials & its application toward prescriptions in small animal practices. K Thungrat, DM Boothe | | 2016 |
ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF CLINICAL ISOLATES OFE. COLIISOLATED FROM DOGS AND CATS IN THE UNITED STATES.: P-8 K Thungrat, D Boothe, S Price, M Carpenter Journal of Veterinary Internal Medicine 28 (3), 2014 | | 2014 |
PREDICTING ASYMPTOMATIC BACTERIURIAESCHERICHIA COLIIN CLINICAL CANINE UROPATHOGENS.: NU-39 K Thungrat, D Boothe Journal of Veterinary Internal Medicine 28 (3), 2014 | | 2014 |
In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates. LXQ Liu XiaoQiang, C Lazzaroni, SA Aly, K Thungrat, DM Boothe | | 2014 |
Epidemiology of the virulence and antimicrobial resistance of Escherichia coli from canine and feline clinical isolates K Thungrat Auburn University, 2014 | | 2014 |
In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States. LXQ Liu XiaoQiang, DM Boothe, JYP Jin YaPing, K Thungrat | | 2013 |